Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.
published in: Actas Dermo-Sifiliográficas
date of publication: 2016-04-26
main subject: diclofenac, actinic keratosis, keratosis
Cites articles
There is nothing here
Article - wd:Q50857264